---
title: "lenvatinib - Papillary thyroid carcinoma"
sidebar: mydoc_sidebar
permalink: lenvatinibpapillarythyroidcarcinoma.html
toc: false 
---

{% include image.html file="lenvatinibpapillarythyroidcarcinoma.png" alt="lenvatinibpapillarythyroidcarcinoma" %}![Path Visualization](/images/lenvatinibpapillarythyroidcarcinoma.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C531958 | lenvatinib | Drug |
| InterPro:IPR009135 | vascular endothelial growth factor receptor | GeneFamily |
| GO:0001525 | angiogenesis | BiologicalProcess |
| GO:0009987 | cellular processes | BiologicalProcess |
| CL:0001064 | cancer cell | Cell |
| MESH:D000077273 | Papillary thyroid carcinoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lenvatinib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor |
| Vascular Endothelial Growth Factor Receptor | NEGATIVELY REGULATES | Angiogenesis |
| Angiogenesis | DISRUPTS | Cellular Processes |
| Cellular Processes | LOCATED IN | Cancer Cell |
| Cancer Cell | PARTICIPATES IN | Papillary Thyroid Carcinoma |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB09078#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB09078#mechanism-of-action){:target="_blank"}